Organogenesis Announces Promising Breakthrough for Knee OA Pain
Organogenesis has secured FDA alignment to begin a rolling Biologics License Application for Renu, a cryopreserved amniotic suspension allograft...
Singlera, Pitt Collaborate on Pancreatic Cancer Detection
Singlera Genomics and Breakthrough Genomics have initiated a research collaboration with the University of Pittsburgh to advance preclinical evaluation...
Peptinovo Announces Breakthrough in Targeted Chemotherapy
PeptiNovo Biopharma has secured a manufacturing and IP milestone that could unlock clinical entry for its targeted chemotherapy platform,...
Dyadic, Fermbox Bio Expand Animal-Free Protein Partnership
Dyadic Applied Biosolutions has expanded its collaboration with Fermbox Bio, granting Fermbox rights to manufacture and commercialize multiple Dyadic-origin...
Rakovina Targets Growth Opportunities at JPM Partnering Week
Rakovina Therapeutics will use JPM Week 2026 to court partners and investors on the back of new preclinical data...
Inventiva Reveals Its Q3 2025 Financial Portfolio Report
Inventiva reported €97.6 million in cash and cash equivalents as of September 30, 2025, €4.5 million in revenue for...
Nanobiotix Q3 2025 Financial Update & 2026 Clinical Outlook
Nanobiotix has closed a non-dilutive royalty financing with Healthcare Royalty for up to $71 million, securing $50 million upfront...
Cellectar & Ionetix Forge Powerful Alpha Therapy Supply Deal
Cellectar Biosciences has signed a multi-year supply agreement with IONETIX for cGMP-grade actinium-225 and astatine-211 to support clinical development...
Vyne Therapeutics and Yarrow Bioscience Announce Merger
Vyne Therapeutics and Yarrow Bioscience will merge in an all-stock transaction to form Yarrow Bioscience, which plans to trade...
Sagimet, TAPI Announce Global Resmetirom API License Deal
Sagimet Biosciences has secured a global, exclusive license from Teva’s TAPI Technology & API Services to use innovative forms...